Abstract
Background; The ninth most prevalent cancer worldwide and the thirteenth major reason of cancer-related fatalities is urinary bladder cancer (BC), Aim and objectives; to evaluate the impact of pretreatment NLR as a clinical outcome predictor in patients with intravesical BCG-treated NMIBC, Subjects and methods; In the El-Hussein hospital and Kobry-Alkobba military hospital, 126 patients with NMIBC participated in this retrospective cohort research, Result; No substantial variation were found between cancer free patients and patients with recurrence at 1st follow up cystoscopy regarding tumor size (p>0.05). Tumor multiplicity showed substantial variation between the two groups as it was substantially greater in cases with recurrence (p
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
